Wilson Sonsini Goodrich & Rosati has released the 2023 Mid-Year Technology and Life Sciences PIPE and RDO Report. Offering insight into venture capital and public market investments in U.S.-based tech and life sciences companies, the report presents a comprehensive analysis of 87 private investments in public equity (PIPEs) and registered direct offerings (RDOs) during the first half of 2023.
The report scrutinizes transactions by operating companies, providing both quantitative and qualitative results in relation to proceeds and security types, registration rights, and transfer restrictions. The findings present a comprehensive view of these dealings in the technology and life sciences sectors, presenting a valuable asset for legal professionals navigating these industries.
Following the overview, the report delves deeper by segmenting the transactions into those made via Private Investments in Public Equity (PIPEs) and those conducted through Registered Direct Offerings (RDOs). PIPEs refer to the selling of publicly traded securities to private investors, whereas RDOs involve the selling of securities directly to an investor, as opposed to issuing shares on the open market.
In the review period, which spans from January 1 to June 30, 2023, the report examines a significant number of transactions, offering a compelling view into the investment landscape in these two rapidly evolving sectors.
As Wilson Sonsini Goodrich & Rosati is a legal advisory firm that particularly specializes in these sectors, the report not only delivers reflective data but also provides prescriptive advice on strategies and structuring of investments. This will be of particular interest to legal professionals who need to stay on top of current trends and legal implications in the tech and life sciences sectors.
For in-depth details on the report and its findings, please refer to the full 2023 Mid-Year Technology and Life Sciences PIPE and RDO Report by Wilson Sonsini Goodrich & Rosati.